Tuesday, August 11, 2020

Most infamous fugitive of Rwanda Genocide captured after 26 year run

This article is by

Share this article

Article Contributor(s)

Charvi Trivedi

Article Title

Most infamous fugitive of Rwanda Genocide captured after 26 year run

Publisher

Global Views 360

Publication Date

August 11, 2020

URL

Felicien Kabuga—The fugitive caught in France

Felicien Kabuga—The fugitive caught in France | US Department of State via Wikimedia

After evading justice for almost 26 years, 84-year-old Felicien Kabuga, the infamous co-founder of the Radio Television Libre des Mille Collines (RTLM) and the most-wanted absconder of Rwanda genocide was arrested in Paris on May 16, 2020.

It was Kabuga’s radio station, Radio Rwanda that played the instrumental role in the horrendous events in Rwanda in 1994. The announcers of Radio Rwanda used inflammatory rhetoric against the Tutsi minority, calling them ‘cockroaches’ which had to be terminated so the Hutu majority would emerge as winners.

Over eight hundred thousand Tutsis and moderate Hutus were massacred in 100 days during the genocide in 1994. Kabuga was held accountable for financing militias and importing machetes which were used in killing.

Claver Irakoze, a survivor of the 1994 events, says, “We prayed to die softly and to go to heaven. People were negotiating over how they should be killed - that was the level of trauma”. Beatrice Uwera, another survivor, recalls that the soldiers went from house to house with lists of names of all the Tutsis and slaughtered people with weapons like machetes and guns.

Felicien Kabuga was implicated on multiple charges like genocide, complicity in genocide, direct and public incitement to commit genocide, attempt to commit genocide, conspiracy to commit genocide, persecution and extermination.

His capture is not only an event of celebration amongst the people of Rwanda but also an indication of improving relations between France and Rwanda. “In the past two months, we came to a conclusion that he was most likely in France and in the region of Paris. We intensified cooperation with French authorities. They were very instrumental in locating the specific apartment where he was. So, cooperation with the police and prosecutor general office in Paris was excellent” says Serge Brammertz, the chief prosecutor of the International Residual Mechanism for Criminal Tribunals (IRMCT).  

Kabuka’s ability to evade law for so long also raises certain queries. For instance, how long was Kabuga residing in France before the officials finally gave him up? “It is difficult to believe that such a high-profile suspect, even with a new identity, could live openly without the French authorities knowing it” states Phil Clark, a professor of International Politics and scholar of the 1994 Genocide against the Tutsi at the London-based School of Oriental and African Studies.

One possible explanation is that Kabuga might have several contacts in Europe who helped him remain under the radar for so long. “It is clear that Kabuga could not have escaped international justice for so long without an extensive network of accomplices, which enabled him to enjoy facilitation from Government institutions in the several African and European countries” says Valentine Rugwabiza, Rwanda’s Permanent Representative to the United Nations.

As Kabuga is being put on trial (so far, he has denied all accusations against him), other complications pop up. International criminal trials and hearings take quite a lot of years, and whether Kabuga will remain alive till all the trials are complete, is still a doubt. Secondly, many questions hover around how the mechanism will judge the monetary parts of Kabuka’s involvement in the genocides.

At last the chief genocide suspect is detained and the Rwandan Government and people hope that the trial does not fall for procedural hurdles and proceed without any unnecessary delay.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More